Heterodinuclear bridged borylene complexes are synthesized via oxidative addition of the B-Br bond of bromoboryl complex precursors to an electron-rich palladium species. The synthetic protocol grants access to the first compound featuring the reactive bromoborylene ligand.
No takes yet. Share an insight, caveat, or question.
Braunschweig et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: